Health Sector Supply Chain Fragility and Investment Prioritization Support Services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The U.S. International Development Finance Corporation intends to award a one-year sole source purchase order to the API Innovation Center for specialized technical and analytical support. The objective is to identify and assess vulnerabilities within pharmaceutical and health-sector supply chains to uncover investment and resilience opportunities. The selected contractor will be responsible for producing national fragility analyses, integrating complex datasets regarding manufacturing and geopolitics, and preparing 20 to 30 drug-specific supply chain reports focusing on active pharmaceutical ingredients and upstream dependencies. This procurement action is being conducted under the authority of FAR 13.106-1(b). While the government intends to negotiate with a single source, interested vendors may submit responses to the contracting officer by August 31, 2026, at 4:30pm Eastern Time. The government will use these responses to determine whether to proceed with a sole source award or transition to a competitive procurement process.
General Info
Agency
NAICS
Place of Performance
DC, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Notice of Sole Source Intent
The U.S. International Development Finance Corporation (DFC) intends to award a one-year, sole source purchase order to API Innovation Center (APIIC) for specialized analytical, technical, data integration, prioritization, reporting, and briefing support to identify, assess, prioritize, and act on pharmaceutical and health-sector supply chain vulnerabilities that may present development finance, investment, counter-dependency, resilience, and strategic supply chain opportunities. The requirement is for a highly specialized contractor capable of producing a national fragility analysis; integrating multiple pharmaceuticals, manufacturing, regulatory, utilization, geopolitical, and risk datasets; assessing API-level supply chain dependency; supporting DFC-calibrated model weighting; prioritizing candidate drugs; and preparing approximately 20–30 drug-specific supply chain reports. The work requires detailed visibility into active pharmaceutical ingredient (API) production, finished dosage form (FDF) manufacturing, key starting material (KSM) and upstream dependencies, manufacturer and facility-level concentration, country-specific dependency risks, and financeable opportunities to reduce supply chain fragility.
This contract action is for services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). Interested vendors may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received by Monday, August 31, 2026, at 4:30pm Eastern Time (ET) will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the Contracting Officer, Melissa Hergenrader, at melissa.hergenrader@dfc.gov by Monday, August 31, 2026, at 4:30pm ET.
Similar Contracts
Same NAICS industry code
More opportunities from United States International Development Finance Corporation → Office Of Acquisition
Same awarding agency